Phase 2 study of S-1 for elderly patients with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 17 Oct 2017 Planned End Date changed from 30 Jun 2019 to 30 Sep 2017.
- 12 Oct 2015 Planned End Date changed from 1 Jun 2015 to 30 Jun 2019 as reported by University Hospital Medical Information Network - Japan.
- 03 Nov 2013 Planned end date (Jun 2015) added as reported by University Hospital Medical Information Network - Japan record.